Peregrine Pharma (PPHM) Reports Statistically Significant Data from Bavituximab Phase IIb
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
Go back to Peregrine Pharma (PPHM) Reports Statistically Significant Data from Bavituximab Phase IIb
September 7, 2012 11:57 AM EDT
Peregrine Pharmaceuticals (Nasdaq: PPHM) halted, news pending... More